Morning Business Report: New cancer treatment cures 14 patients in experimental trial
New data on a breast cancer treatment from AstraZeneca and Japanese drug maker Daiichi Sankyo brought a standing ovation in their annual meeting in Chicago. The drug, Enhertu, enabled women to live six months longer than other conventional means of Chemotherapy. Evidence suggests this drug could be used to treat other types of tumors, after six months of experimental treatment,…